Westside Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
500
| – | – | ﹤0.01% | 1537 |
|
|
2025
Q4 | $0 | Hold |
500
| – | – | ﹤0.01% | 1551 |
|
|
2025
Q3 | $0 | Hold |
500
| – | – | ﹤0.01% | 1430 |
|
|
2025
Q2 | $0 | Hold |
500
| – | – | ﹤0.01% | 1326 |
|
|
2025
Q1 | $0 | Hold |
500
| – | – | ﹤0.01% | 1015 |
|
|
2024
Q4 | $0 | Hold |
500
| – | – | ﹤0.01% | 1029 |
|
|
2024
Q3 | $0 | Hold |
500
| – | – | ﹤0.01% | 1020 |
|
|
2024
Q2 | $0 | Hold |
500
| – | – | ﹤0.01% | 1010 |
|
|
2024
Q1 | $0 | Hold |
500
| – | – | ﹤0.01% | 921 |
|
|
2023
Q4 | $0 | Hold |
500
| – | – | ﹤0.01% | 891 |
|
|
2023
Q3 | $0 | Hold |
500
| – | – | ﹤0.01% | 862 |
|
|
2023
Q2 | $0 | Hold |
500
| – | – | ﹤0.01% | 861 |
|
|
2023
Q1 | $0 | Hold |
500
| – | – | ﹤0.01% | 859 |
|
|
2022
Q4 | $0 | Hold |
500
| – | – | ﹤0.01% | 873 |
|
|
2022
Q3 | $0 | Hold |
500
| – | – | ﹤0.01% | 869 |
|
|
2022
Q2 | $0 | Hold |
500
| – | – | ﹤0.01% | 856 |
|
|
2022
Q1 | $0 | Hold |
500
| – | – | ﹤0.01% | 835 |
|
|
2021
Q4 | $0 | Hold |
500
| – | – | ﹤0.01% | 808 |
|
|
2021
Q3 | $0 | Hold |
500
| – | – | ﹤0.01% | 789 |
|
|
2021
Q2 | $0 | Hold |
500
| – | – | ﹤0.01% | 776 |
|
|
2021
Q1 | $0 | Hold |
500
| – | – | ﹤0.01% | 766 |
|
|
2020
Q4 | $1.24K | Hold |
500
| – | – | ﹤0.01% | 187 |
|
|
2020
Q3 | $1.57K | Hold |
500
| – | – | ﹤0.01% | 186 |
|
|
2020
Q2 | $1.46K | Sell |
500
-36,334
| -99% | -$115K | ﹤0.01% | 165 |
|
|
2020
Q1 | $406K | Buy |
+36,834
| New | +$119K | 0.28% | 9 |
|
|
2019
Q2 | $1.9K | Buy |
+500
| New | +$1.62K | ﹤0.01% | 97 |
|
|
2018
Q4 | $1.58K | Hold |
500
| – | – | ﹤0.01% | 638 |
|
|
2018
Q3 | $1.26K | Hold |
500
| – | – | ﹤0.01% | 694 |
|
|
2018
Q2 | $1.28K | Buy |
+500
| New | +$1.4K | ﹤0.01% | 782 |
|
|
2017
Q2 | – | Sell |
-500
| Closed | -$1.06K | – | 837 |
|
|
2017
Q1 | $1.06K | Hold |
500
| – | – | ﹤0.01% | 740 |
|
|
2016
Q4 | $1.16K | Buy |
+500
| New | +$1.4K | ﹤0.01% | 607 |
|
Other funds holding PDLI
Westside Investment Management's PDLI Position: Q1 2026 in Review
Westside Investment Management held its PDL BioPharma, Inc. (PDLI) position steady in Q1 2026 at 500 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1537.
Westside Investment Management first reported a position in PDLI in Q4 2016 and has held it in 31 quarters since. The position peaked at $406K in Q1 2020. 6 funds tracked by Wall St. Rank hold PDLI as of Q1 2026.
- Westside Investment Management held 500 shares of PDL BioPharma, Inc. worth $0 as of Q1 2026.
- Westside Investment Management left its PDL BioPharma, Inc. share count unchanged in Q1 2026.
- PDL BioPharma, Inc. made up ﹤0.01% of Westside Investment Management's portfolio in Q1 2026, its #1537 holding.
- Westside Investment Management first reported a position in PDL BioPharma, Inc. in Q4 2016 and has held it in 31 quarters since.
- Westside Investment Management's PDL BioPharma, Inc. position peaked at $406K in Q1 2020.
- 6 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2026.
Based on Westside Investment Management's 13F filing for Q1 2026, filed 4 May 2026.